Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
51
OGN Quote, Financials, Valuation and Earnings
Last price:
$9.63
Seasonality move
:
-11.52%
Day range:
$9.55 - $9.81
52-week range:
$8.01 - $23.10
Dividend yield:
8.93%
P/E ratio:
3.34x
P/S ratio:
0.40x
P/B ratio:
4.62x
Volume:
3.4M
Avg. volume:
3.8M
1-year change:
-53.72%
Market cap:
$2.5B
Revenue:
$6.4B
EPS (TTM):
$2.88
Earnings Data
Next earnings date for OGN
Aug 06
2025
Most recent earnings per share
$0.33
Missed by $0.56
(May 1/2025)
Consensus Estimate
$0.89
(May 1/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
OGN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $1.6B | -- | -- | $0.94 | -- |
| 08/06/2025 | Q2 | $1.6B | -- | -- | $0.94 | -- |
| 05/01/2025 | Q1 | $1.5B | $1.5B | $0.33 | $0.89 | -$0.56 |
| 02/13/2025 | Q4 | $1.6B | $1.6B | $0.42 | $0.87 | -$0.45 |
| 10/31/2024 | Q3 | $1.6B | $1.6B | $1.38 | $0.90 | $0.48 |
| 08/06/2024 | Q2 | $1.6B | $1.6B | $0.75 | $1.08 | -$0.33 |
| 05/02/2024 | Q1 | $1.6B | $1.6B | $0.78 | $0.93 | -$0.15 |
| 02/15/2024 | Q4 | $1.5B | $1.6B | $2.13 | $0.83 | $1.30 |
| 11/02/2023 | Q3 | -- | -- | $0.23 | $1.06 | -$0.83 |
| 08/08/2023 | Q2 | -- | -- | $0.95 | $0.99 | -$0.04 |
| 05/04/2023 | Q1 | -- | -- | $0.69 | $1.16 | -$0.47 |
| 02/16/2023 | Q4 | -- | -- | $0.42 | $0.91 | -$0.49 |
| 11/03/2022 | Q3 | -- | -- | $0.89 | $1.10 | -$0.21 |
| 08/04/2022 | Q2 | -- | -- | $0.92 | $1.19 | -$0.27 |
| 05/05/2022 | Q1 | -- | -- | $1.36 | $1.30 | $0.06 |
| 02/17/2022 | Q4 | -- | -- | $0.79 | $1.27 | -$0.48 |
| 11/11/2021 | Q3 | -- | -- | $1.27 | $1.44 | -$0.17 |
| 08/12/2021 | Q2 | -- | -- | $1.68 | $1.43 | $0.25 |
| 06/21/2021 | Q1 | -- | -- | $1.58 | $1.57 | $0.01 |
| 12/31/2020 | Q4 | -- | -- | $1.45 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | $2.14 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | $2.78 | -- | -- |
Organon & Earnings Questions
-
How Much did Organon & Generate in Revenue Last Quarter?
Organon & reported $1.5B worth of top line sales in its most recent quarter.
-
Did Organon & Beat Earnings Last Quarter?
Organon & announced earnings per share of $0.33 which represents a miss of analyst forecast a $0.89 per share.
-
Is Organon & Profitable?
Organon & reported $841M that represents $3.22 per share over the last quarter.
-
What is the Analyst Consensus for Organon & EPS Next Year?
Organon &'s earnings are forecast to grow from $3.33 per share to $4.11 per share next year representing an increase of 15.95%.
-
When is Organon &'s Earnings Date?
Organon &'s next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
